Synthesis, biological evaluation and molecular docking studies of pyrazole derivatives coupling with a thiourea moiety as novel CDKs inhibitors. 2013

Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, People's Republic of China.

It was discovered that a number of cyclin dependent kinase inhibitors containing the pyrazole core structure exhibited high inhibitory potency against broad-range CDKs and corresponding anti-proliferative activities. This information guided us to design and synthesize a series of 1,3-diphenyl-N-(phenylcarbamothioyl)-1H-pyrazole-4-carboxamide derivatives (5a-10d), and evaluate their biological activities as CDKs inhibitors. Among all the synthesized compounds, compound 10b inhibited CDK2 with an IC50 value of 25 nM, counteracting tumor cell proliferation of three cancer cell lines (H460, MCF-7, A549) in the micromolar range (from 0.75 μM to 4.21 μM), In addition, flow cytometry indicated that compound 10b could induce cycle G0/G1 phase arrest in A549 cells with a dose dependent. Taken together, compound 10b could be selected for further preclinical evaluation.

UI MeSH Term Description Entries
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013890 Thiourea A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
June 2020, Bioorganic chemistry,
Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
December 2015, Bioorganic chemistry,
Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
May 2019, Bioorganic chemistry,
Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
July 2013, Bioorganic & medicinal chemistry,
Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
November 2023, Chemistry & biodiversity,
Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
February 2019, Bioorganic & medicinal chemistry,
Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
August 2017, Pest management science,
Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
November 2016, European journal of medicinal chemistry,
Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
April 2017, Molecules (Basel, Switzerland),
Jian Sun, and Xian-Hai Lv, and Han-Yue Qiu, and Yan-Ting Wang, and Qian-Ru Du, and Dong-Dong Li, and Yong-Hua Yang, and Hai-Liang Zhu
April 2022, Bioorganic chemistry,
Copied contents to your clipboard!